12 Pluvicto Indications: Prostate cancerIndications: Prostate cancerR&D company: NovartisR&D company: NovartisDate of approval: 3 JanuaryDate of approval: 3 JanuaryPluvicto is approved for the treatment of adults with advanced prostate-specific membrane antigen-positive, metastatic castration-resistant prostate cancer (mCRPC) who have received androgen receptor pathway inhibitor therapy and taxane-based chemotherapy.
Helima Croft, head of global commodity strategy at RBC Capital Markets, said: "There are inherent limitations to using SPR to mitigate rising gasoline prices in the current situation.
com; Some new PCSK9 drugsInclisiran is injected subcutaneously twice a yearInclisiran is injected subcutaneously twice a yearOn June 28, 2020, the clinical application IND of the PCSK9 small molecule interfering RNA (siRNA, Small Interfering RNA Drug) cholesterol-lowering drug inclisiran, pioneered by Novartis, was accepted by CDE in China for the first time 。 Novartis acquired The Medicines Company in November 2019 through the acquisition of The Medicines Company for US$9.
Global Coatings Network News: Recently, the Development and Reform Commission of Jiangsu Province issued a review opinion on the energy saving report of the project with an annual output of 180,000 tons of high-performance coatings and 20,000 tons of waterborne coatings invested by Haihong Old Man Paint (Zhangjiagang) Co.
" Studies in California prisons have found that recent vaccinations and boosters have reduced contagiousness, but the risk of infection remains highAccording to researchers at the University of California, San Francisco who analyzed transmission between people living in the same cell, vaccination helped limit the spread of COVID-19 in California prisons during the first wave of Omicron.
In order to better promote and advocate a healthy lifestyle and implement the Healthy China - Reasonable Diet Action, the 2022 National Science Popularization Day and National Healthy Lifestyle Publi
The mainstream ex-factory quotations have dropped by 20 yuan to 1,360 yuan, and outbound shipments have been slightly lower by 20-40 yuan. The mainstream ex-factory quotations have dropped by 20 yuan to 1,360 yuan, and outbound shipments have been slightly lower by 20-40 yuan.
It is reported that the plant is expected to shut down in May 2016, and it is planned to be shut down for about 4-5 weeks .
Recently, PPG Industries announced that it will sell nearly 40% of its shares in the Pittsburgh Glass Plant (PGW) to LKQ . Recently, PPG Industries announced that it will sell nearly 40% of its shares in the Pittsburgh Glass Plant (PGW) to LKQ .